Robert Buckland

Senior research engineer at Department of Medical Biosciences
Work Environment Representative

Publications

Author

Title

Year sorteringsordning

Fulltext

Valencia, Liliana
Randazzo, Andres
Engfeldt, Peter; et al.

Identification of novel genetic variants in the mutational hotspot region 14kb upstream of the LCT gene in a Mexican population
Scandinavian Journal of Clinical and Laboratory Investigation, 77(5): 311-314

2017

-

Watt, Danielle L.
Buckland, Robert J.
Lujan, Scott A.; et al.

Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools
Nucleic Acids Research, 44(4): 1669-1680

2016

Download

Rentoft, Matilda
Lindell, Kristoffer
Tran, Phong; et al.

Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance
Proceedings of the National Academy of Sciences of the United States of America, 113(17): 4723-4728

2016

-

Jia, Shaodong
Marjavaara, Lisette
Buckland, Robert; et al.

Determination of deoxyribonucleoside triphosphate concentrations in yeast cells by strong anion-exchange high-performance liquid chromatography coupled with ultraviolet detection

2015

-

Buckland, Robert

DNA precursor asymmetries, Mismatch Repair and their effect on mutation specificity

2015

Download

Buckland, Robert J
Watt, Danielle L
Chittoor, Balasubramanyam; et al.

Increased and Imbalanced dNTP Pools Symmetrically Promote Both Leading and Lagging Strand Replication Infidelity
PLOS Genetics, 10(12)

2014

Download

Hoch, Nicolas C
Chen, Eric S-W
Buckland, Robert; et al.

Molecular basis of the essential s phase function of the rad53 checkpoint kinase
Molecular and Cellular Biology, 33(16): 3202-3213

2013

-

Judge, Heather M
Buckland, Robert J
Sugidachi, Atsuhiro; et al.

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.
Thrombosis and Haemostasis, 103(6)

2010

-

Judge, H M
Patil, S B
Buckland, R J; et al.

Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel.
Journal of Thrombosis and Haemostasis, 8(8)

2010

-

Judge, Heather M
Buckland, Robert J
Sugidachi, Atsuhiro; et al.

The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
Platelets, 19(2)

2008

-


Page Editor: Clas Wikström

Print page